Clovis Oncology Inc logo

Clovis Oncology Inc

1
1
OTCPK:CLVSQ (USA)  
(Delisted) $ 0.02 0 (0%) 03:49 PM EST
At Loss
Enterprise V:
$ 624.47M
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
-

Business Description

Description
Clovis Oncology Inc is a biopharmaceutical company. It is focused on acquiring, developing, and commercializing anti-cancer agents in the United States, the EU, and additional international markets. The firm targets its development programs for the treatment of specific subsets of cancer populations. Its product candidate includes Rucaparib. Rucaparib is an oral small molecule inhibitor of poly ADP-ribose polymerase, is marketed in the United States for two indications specific to the recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. The company has two segments U.S and ex-U.S based on geograhic areas, with majority of its revenue coming from U.S.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 50.06
9-Day RSI 42.32
14-Day RSI 40.29
6-1 Month Momentum % -63.51
12-1 Month Momentum % -99.03

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -132.19

GF Value Rank

Name Current Vs Industry Vs History
EV-to-Forward-Revenue 4.77

Financials (Next Earnings Date:2024-05-04 Est.)

CLVSQ's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CLVSQ

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Clovis Oncology Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 133.021
EPS (TTM) ($) -1.82
Beta 0
Volatility % 234.26
14-Day RSI 40.29
14-Day ATR ($) 0.007335
20-Day SMA ($) 0.019341
12-1 Month Momentum % -99.03
52-Week Range ($) 0.0102 - 2.87
Shares Outstanding (Mil) 144.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clovis Oncology Inc Filings

Filing Date Document Date Form
No Filing Data

Clovis Oncology Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Clovis Oncology Inc Frequently Asked Questions

What is Clovis Oncology Inc(CLVSQ)'s stock price today?
The current price of CLVSQ is $0.02. The 52 week high of CLVSQ is $2.87 and 52 week low is $0.01.
When is next earnings date of Clovis Oncology Inc(CLVSQ)?
The next earnings date of Clovis Oncology Inc(CLVSQ) is 2024-05-04 Est..
Does Clovis Oncology Inc(CLVSQ) pay dividends? If so, how much?
Clovis Oncology Inc(CLVSQ) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1